Product category:
Contract research
News Release from: RiboTargets
Edited by the Laboratorytalk Editorial
Team on 28 May 2002
Top safety award for drug discovery firm
RiboTargets wins one of only 1000 National Safety Awards from the British Safety Council
RiboTargets, a structure-based drug discovery company that develops novel anti-bacterial and anti-cancer therapeutics, has won a prestigious safety award from the British Safety Council The company is one of only 1000 winners from large and small enterprises all over the country in the pubic and private sectors
This article was originally published on Laboratorytalk on 24 Feb 2003 at 8.00am (UK)
Related stories
First spinal study of bone substitute
Study will measure performance of synthetic bone graft substitute in 30 patients undergoing spinal fusion for degenerative disc disease
They faced a tough test in order to satisfy the independent awards panel.
Winners must have lower than average accident rates, good safety policies and safety plans and commitment to health and safety at the highest board level.
They must detail their health and safety officers' qualifications and provide details of significant advances in health and safety for the year, plus notification of any impending health and safety legal action.
David Ballard, director of the British Safety Council, said, "The National Safety Awards highlight organisations that reach top levels of health and safety.
They are a mark of a proven and significant achievement in safety standards.
By making safety an important feature of everyday work practice, RiboTargets is reducing accidents and ill health while improving productivity and profitability." Simon Sturge, RiboTargets CEO, commented, "The safety and well-being of our staff always comes first and this award emphasises our continued commitment to a safe and stimulating work environment.".
• RiboTargets: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
